Dermatomyositis in patients with rheumatoid arthritis during adalimumab therapy

Journal of Rheumatology

Volumn 38, Issue 3, 2011, Pages 574-

  Nagashima, Takao ^a   Minota, Seiji ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; METHOTREXATE; PREDNISONE; TUMOR NECROSIS FACTOR INHIBITOR;

ANKYLOSING SPONDYLITIS; AUTOIMMUNE DISEASE; DERMATOMYOSITIS; DISEASE ASSOCIATION; DRUG WITHDRAWAL; ENTERITIS; HUMAN; LETTER; LUPUS ERYTHEMATOSUS; LUPUS LIKE SYNDROME; POLYMYOSITIS; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; TREATMENT DURATION; VASCULITIS;

ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DERMATOMYOSITIS; HUMANS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79952373610     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.100947     Document Type: Letter

References (10)

1. Brunasso AM, Scocco GL, Massone C. Dermatomyositis during adalimumab therapy for rheumatoid arthritis. J Rheumatol 2010;37:1549-50.
2. Martínez-Cordero E, León DE, Ortega LA. Association of polymyositis with rheumatoid arthritis. Rheumatol Int 2001;20:119-23. (Pubitemid 32250124)
3. Nagashima T, Sato H, Minota S. Destructive arthropathy associated with dermatomyositis sine myositis positive for anti-Jo-1 and anti-cyclic citrullinated peptide antibodies. J Rheumatol 2009;36:2133-4.
4. Nagashima T, Onishi S, Kamata Y, Minota S. Dermatomyositis associated with thyroid cancer: a paraneoplastic syndrome? Rheumatol Int 2009;29:1261-2.
5. Nagashima T, Iwamoto M, Minota S. Antisynthetase syndrome associated with long-standing rheumatoid arthritis. Rheumatol Int 2010 Mar 30. [Epub ahead of print]
6. Ramos-Casals M, Brito-Zeron P, Munoz S, Soria N, Galiana D, Bertolaccini L, et al. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine 2007;86:242-51. (Pubitemid 47067483)
7. De Bandt M, Sibilia J, Le Loet X, Prouzeau S, Fautrel B, Marcelli C, et al. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey. Arthritis Res Ther 2005;7:R545-51.
8. Callen JP. Immunomodulatory treatment for dermatomyositis. Curr Allergy Asthma Rep 2008;8:348-53.
9. Nagashima T, Minota S. Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment? Clin Rheumatol 2010;29:819-20.
10. Klein R, Rosenbach M, Kim EJ, Kim B, Werth VP, Dunham J. Tumor necrosis factor inhibitor-associated dermatomyositis. Arch Dermatol 2010;146:780-4.